alanine has been researched along with mefloquine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barreto-Vieira, DF; Blanco, C; Bou-Habib, DC; Bozza, PT; Chaves, OA; Da Silva, APD; da Silva, CS; da Silva, MAN; Dias, SSG; Ferreira, AC; Fintelman-Rodrigues, N; Mattos, M; Miranda, MD; Owen, A; Paccanaro, A; Pereira-Dutra, F; Rajoli, RKR; Sacramento, CQ; Santos, SS; Soares, VC; Souza, TML; Temerozo, JR; Torres, M | 1 |
1 other study(ies) available for alanine and mefloquine
| Article | Year |
|---|---|
Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.
Topics: Adenosine Monophosphate; Alanine; Alveolar Epithelial Cells; Antiviral Agents; Cell Line; Chloroquine; COVID-19 Drug Treatment; Drug Repositioning; Humans; Mefloquine; SARS-CoV-2; Serine Endopeptidases; Virus Internalization | 2022 |